Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Quinine products are in shortage in Canada (2 of 11 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
An antimalarial medicine used to treat malaria.
Products affected
2 / 11
In shortage since
Apr 1, 2020
Reports on file
30
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
JAMP-QUININE
300MG · CAPSULE · JAMP PHARMA CORPORATION
DIN 02445204 · since Apr 1, 2020, est. end Dec 30, 2022 · Disruption of the manufacture of the drug.
Active shortage
JAMP-QUININE
200MG · CAPSULE · JAMP PHARMA CORPORATION
DIN 02445190 · since Apr 1, 2020, est. end Dec 30, 2022 · Disruption of the manufacture of the drug.
Resolved
TEVA-QUININE
300MG · CAPSULE · TEVA CANADA LIMITED
DIN 00021016 · ended Jun 3, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-QUININE
300MG · CAPSULE · TEVA CANADA LIMITED
DIN 00021016 · ended Oct 29, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-QUININE
200MG · CAPSULE · TEVA CANADA LIMITED
DIN 00021008 · ended Oct 29, 2025 · Disruption of the manufacture of the drug.
Resolved
PRO-QUININE - 200
200MG · CAPSULE · PRO DOC LIMITEE
DIN 02311216 · ended Jun 21, 2023 · Delay in shipping of the drug.
Discontinued
QUININE - ODAN
200MG · CAPSULE · ODAN LABORATORIES LTD
DIN 00695440
Resolved
QUININE - ODAN
300MG · CAPSULE · ODAN LABORATORIES LTD
DIN 00695459 · ended Dec 30, 2022 · Delay in shipping of the drug.
Resolved
TEVA-QUININE
300MG · CAPSULE · TEVA CANADA LIMITED
DIN 00021016 · ended Dec 7, 2022 · Disruption of the manufacture of the drug.
Resolved
TEVA-QUININE
200MG · CAPSULE · TEVA CANADA LIMITED
DIN 00021008 · ended Dec 7, 2022 · Disruption of the manufacture of the drug.
Resolved
TEVA-QUININE
200MG · CAPSULE · TEVA CANADA LIMITED
DIN 00021008 · ended Jan 19, 2022 · Disruption of the manufacture of the drug.
Discontinued
APO-QUININE
300MG · CAPSULE · APOTEX INC
DIN 02254522
Showing 12 of 30 reports. All reports are on file with Health Canada.
What's happening
Quinine is currently affected by 2 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Quinine is classified under “ANTIMALARIALS” (ATC P01BC).
Recent changes
No changes recorded yet.
Common questions
What is Quinine used for?
An antimalarial medicine used to treat malaria.
When will Quinine be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Quinine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Possible alternatives in the same class (antimalarials)
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.